blue cross blue shield and glp 1 BCBSM pulling back on GLP-1 coverage GLP-1 Denied? Zepbound & Wegovy

On November 6, 2025, the president announced that agreements have been reached with Eli Lilly and Novo Nordisk, the manufacturers of the three available GLP-1s for weight loss, to reduce the drugs prices

The oral DPP-4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitus

Ten ma tylko rejestracj do leczenia cukrzycy

The most common side effects of GLP-1 receptor agonists include nausea, vomiting, constipation, and diarrhea

Even though GLP-1 RAs mimic a natural hormone in the body, they do have some potential GI side effects, including constipation, which appears to be more common than diarrhea in patients who reach out to Oshi Health for help

Systemic side effects related to Wegovy can vary